|
[1]
|
Sender, R., Fuchs, S. and Milo, R. (2016) Revised Estimates for the Number of Human and Bacteria Cells in the Body. PLOS Biology, 14, e1002533. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Holzapfel, W.H., Haberer, P., Snel, J., et al. (1998) Overview of Gut Flora and Probiotics. International Journal of Food Microbiology, 41, 85-101. [Google Scholar] [CrossRef]
|
|
[3]
|
(2021) 2021 Alzheimer’s Disease Facts and Figures. Alz-heimer’s & Dementia: The Journal of the Alzheimer’s Association, 17, 327-406. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Kumar, A., Sidhu, J., Goyal, A., et al. (2023) Alzheimer Disease. StatPearls, Treasure Island.
|
|
[5]
|
Armstrong, M.J. and Okun, M.S. (2020) Diagnosis and Treatment of Parkinson Disease: A Re-view. JAMA, 323, 548- 560. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Ye, H., Robak, L.A., Yu, M., et al. (2023) Genetics and Pathogenesis of Parkinson’s Syndrome. Annual Review of Pathology, 18, 95-121. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Xie, A., Ensink, E., Li, P., et al. (2022) Bacteri-al Butyrate in Parkinson’s Disease Is Linked to Epigenetic Changes and Depressive Symptoms. Movement Disorders, 37, 1644-1653. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Kim, S.Y., Chae, C.W., Lee, H.J., et al. (2020) Sodium Butyr-ate Inhibits High Cholesterol-Induced Neuronal Amyloidogenesis by Modulating NRF2 Stabilization-Mediated ROS Levels: Involvement of NOX2 and SOD1. Cell Death & Disease, 11, Article No. 469. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Braak, H., Del, Tredici, K., Rüb, U., et al. (2003) Staging of Brain Pathology Related to Sporadic Parkinson’s Disease. Neurobiology of Aging, 24, 197-211. [Google Scholar] [CrossRef]
|
|
[10]
|
Sun, M.F., Zhu, Y.L., Zhou, Z.L., et al. (2018) Neuroprotec-tive Effects of Fecal Microbiota Transplantation on MPTP-Induced Parkinson’s Disease Mice: Gut Microbiota, Glial Reaction and TLR4/TNF-α Signaling Pathway. Brain, Behavior, and Immunity, 70, 48-60. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Chen, S.J., Chen, C.C., Liao, H.Y., et al. (2022) Association of Fe-cal and Plasma Levels of Short-Chain Fatty Acids with Gut Microbiota and Clinical Severity in Patients with Parkinson Disease. Neurology, 98, E848-E858. [Google Scholar] [CrossRef]
|
|
[12]
|
Xu, R.C., Miao, W.T., Xu, J.Y., et al. (2022) Neuroprotec-tive Effects of Sodium Butyrate and Monomethyl Fumarate Treatment through GPR109A Modulation and Intestinal Bar-rier Restoration on PD Mice. Nutrients, 14, Article No. 4163. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Chang, S.C., Shen, M.H., Liu, C.Y., et al. (2020) A Gut Butyrate-Producing Bacterium Butyricicoccus Pullicaecorum Regulates Short-Chain Fatty Acid Transporter and Receptor to Reduce the Progression of 1,2-Dimethylhydrazine- Associated Col-orectal Cancer. Oncology Letters, 20, Article No. 327. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Jung, T.H., Park, J.H., Jeon, W.M., et al. (2015) Butyrate Modulates Bacterial Adherence on LS174T Human Colorectal Cells by Stimu-lating Mucin Secretion and MAPK Signaling Pathway. Nutrition Research and Practice, 9, 343-349. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Sharma, S., Taliyan, R. and Singh, S. (2015) Beneficial Effects of Sodium Butyrate in 6-OHDA Induced Neurotoxicity and Behavioral Abnormalities: Modulation of Histone Deacetylase Activity. Behavioural Brain Research, 291, 306- 314. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Fernando, W., Martins, I.J., Morici, M., et al. (2020) Sodium Butyrate Reduces Brain Amyloid-β Levels and Improves Cognitive Memory Performance in an Alzheimer’s Disease Transgenic Mouse Model at an Early Disease Stage. Journal of Alz-heimer’s Disease: JAD, 74, 91-99. [Google Scholar] [CrossRef]
|
|
[17]
|
Huang, F., Wang, M., Liu, R., et al. (2019) CDT2-Controlled Cell Cycle Reentry Regulates the Pathogenesis of Alzheimer’s Disease. Alzheimer’s & Demen-tia: The Journal of the Alzheimer’s Association, 15, 217-231. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
La Rosa, F., Clerici, M., Ratto, D., et al. (2018) The Gut-Brain Axis in Alzheimer’s Disease and Omega-3. A Critical Overview of Clinical Trials. Nutrients, 10, Article No. 1267. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Keogh, C.E., Kim, D.H.J., Pusceddu, M.M., et al. (2021) Myelin as a Regulator of Development of the Microbiota-Gut-Brain Axis. Brain, Behavior, and Immunity, 91, 437-450. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Marizzoni, M., Cattaneo, A., Mirabelli, P., et al. (2020) Short-Chain Fatty Acids and Lipopolysaccharide as Mediators between Gut Dysbiosis and Amyloid Pathology in Alzheimer’s Dis-ease. Journal of Alzheimer’s Disease: JAD, 78, 683-697. [Google Scholar] [CrossRef]
|
|
[21]
|
Wood, H. (2019) New Models Show Gut-Brain Transmission of Parkinson Disease Pathology. Nature Reviews Neurology, 15, Article No. 491. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Kim, S., Kwon, S.H., Kam, T.I., et al. (2019) Transneuronal Propagation of Pathologic Alpha-Synuclein from the Gut to the Brain Models Parkinson’s Disease. Neu-ron, 103, 627-641e7. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Hu, S., Tan, J., Qin, L., et al. (2021) Mo-lecular Chaperones and Parkinson’s Disease. Neurobiology of Disease, 160, Article ID: 105527. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Ji, S., Wang, C., Qiao, H., et al. (2020) Decreased Penetrance of Parkinson’s Disease in Elderly Carriers of Glucocerebrosidase Gene L444P/R Mutations: A Community-Based 10-Year Longitudinal Study. Movement Disorders, 35, 672- 678. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Caputi, V. and Giron, M.C. (2018) Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson’s Disease. International Journal of Molecular Sciences, 19, Article No. 1689. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Lin, C.H., Chen, C.C., Chiang, H.L., et al. (2019) Altered Gut Microbiota and Inflammatory Cytokine Responses in Patients with Parkinson’s Disease. Journal of Neuroinflammation, 16, Article No. 129. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Munoz-Delgado, L., Macias-Garcia, D., Jesus, S., et al. (2021) Peripheral Immune Profile and Neutrophil-TO-Lym- phocyte Ratio in Parkinson’s Disease. Movement Disorders, 36, 2426-2430. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Jensen, M.P., Jacobs, B.M., Dobson, R., et al. (2021) Lower Lymphocyte Count Is Associated with Increased Risk of Parkinson’s Disease. Annals of Neurology, 89, 803-812. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Liscovitch, N. and French, L. (2014) Differential Co-Expression between α-Synuclein and IFN-γ Signaling Genes across Development and in Parkinson’s Disease. PLOS ONE, 9, e115029. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Breyner, N.M., Michon, C., De, Sousa, C.S., et al. (2017) Mi-crobial Anti-Inflammatory Molecule (MAM) from Faecalibacterium prausnitzii Shows a Protective Effect on DNBS and DSS-Induced Colitis Model in Mice through Inhibition of NF-κB Pathway. Frontiers in Microbiology, 8, Article No. 114. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Miquel, S., Leclerc, M., Martin, R., et al. (2015) Identification of Metabolic Signatures Linked to Anti-Inflammatory Effects of Faecalibacterium prausnitzii. MBio, 6, e00300-15. [Google Scholar] [CrossRef]
|
|
[32]
|
Ueda, A., Shinkai, S., Shiroma, H., et al. (2021) Identification of Faecalibacterium prausnitzii Strains for Gut Microbiome-Based Intervention in Alzheimer’s-Type Dementia. Cell Re-ports Medicine, 2, Article ID: 100398. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Unger, M.M., Spiegel, J., Dillmann, K.U., et al. (2016) Short Chain Fatty Acids and Gut Microbiota Differ between Patients with Parkinson’s Disease and Age-Matched Controls. Parkinsonism & Related Disorders, 32, 66-72. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Duncan, S.H., Hold, G.L., Barcenilla, A., et al. (2002) Rose-buria intestinalis sp. Nov., a Novel Saccharolytic, Butyrate-Producing Bacterium from Human Faeces. International Journal of Systematic and Evolutionary Microbiology, 52, 1615-1620. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Verhaar, B.J.H., Hendriksen, H.M.A., De, Leeuw, F.A., et al. (2021) Gut Microbiota Composition Is Related to AD Pathology. Frontiers in Immunology, 12, Article ID: 794519. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Lu, H., Xu, X., Fu, D., et al. (2022) Butyrate-Producing Eubac-terium Rectale Suppresses Lymphomagenesis by Alleviating the TNF-Induced TLR4/MyD88/NF-κB Axis. Cell Host & Microbe, 30, 1139-1150.E7. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Zhuang, Z., Yang, R., Wang, W., et al. (2020) Associations be-tween Gut Microbiota and Alzheimer’s Disease, Major Depressive Disorder, and Schizophrenia. Journal of Neuroin-flammation, 17, Article No. 288. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Bedarf, J.R., Hildebrand, F., Coelho, L.P., et al. (2017) Func-tional Implications of Microbial and Viral Gut Metagenome Changes in Early Stage L-DOPA-Naïve Parkinson’s Disease Patients. Genome Medicine, 9, Article No. 39. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Hiippala, K., Barreto, G., Burrello, C., et al. (2020) Novel Odori-bacter Splanchnicus Strain and Its Outer Membrane Vesicles Exert Immunoregulatory Effects in Vitro. Frontiers in Mi-crobiology, 11, Article ID: 575455. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Xing, C., Wang, M., Ajibade, A.A., et al. (2021) Microbiota Reg-ulate Innate Immune Signaling and Protective Immunity against Cancer. Cell Host & Microbe, 29, 959-974.E7. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Avagliano, C., Coretti, L., Lama, A., et al. (2022) Dual-Hit Model of Parkinson’s Disease: Impact of Dysbiosis on 6-Hydroxydopamine-Insulted Mice—Neuroprotective and An-ti-Inflammatory Effects of Butyrate. International Journal of Molecular Sciences, 23, Article No. 6367. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Liu, X., Mao, B., Gu, J., et al. (2021) Blautia—A New Functional Ge-nus with Potential Probiotic Properties? Gut Microbes, 13, Article ID: 1875796. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Wang, Y.J., Abdugheni, R., Liu, C., et al. (2021) Blautia in-testinalis Sp. Nov., Isolated from Human Feces. International Journal of Systematic and Evolutionary Microbiology, 71. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Guo, X., Tang, P., Hou, C., et al. (2022) Integrated Microbiome and Host Transcriptome Profiles Link Parkinson’s Disease to Blautia Genus: Evidence from Feces, Blood, and Brain. Fron-tiers in Microbiology, 13, Article ID: 875101. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Liu, M., Xie, W., Wan, X., et al. (2020) Clostridium butyricum Protects Intestinal Barrier Function via Upregulation of Tight Junction Proteins and Activation of the Akt/MTOR Signal-ing Pathway in a Mouse Model of Dextran Sodium Sulfate-Induced Colitis. Experimental and Therapeutic Medicine, 20, Article No. 10. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Akhtar, A. and Sah, S.P. (2020) Insulin Signaling Pathway and Related Molecules: Role in Neurodegeneration and Alzheimer’s Disease. Neurochemistry International, 135, Article ID: 104707. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Hu, M., Chen, Y., Deng, F., et al. (2022) D-Mannose Regulates Hepatocyte Lipid Metabolism via PI3K/Akt/MTOR Signaling Pathway and Ameliorates Hepatic Steatosis in Alcoholic Liver Disease. Frontiers in Immunology, 13, Article ID: 877650. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
Huang, T.T., Lampert, E.J., Coots, C., et al. (2020) Targeting the PI3K Pathway and DNA Damage Response as a Therapeutic Strategy in Ovarian Cancer. Cancer Treatment Reviews, 86, Article ID: 102021. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Sun, J., Xu, J., Yang, B., et al. (2020) Effect of Clostridium butyr-icum against Microglia-Mediated Neuroinflammation in Alzheimer’s Disease via Regulating Gut Microbiota and Metabo-lites Butyrate. Molecular Nutrition & Food Research, 64, e1900636. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Sun, J., Li, H., Jin, Y., et al. (2021) Probiotic Clostridium butyricum Ameliorated Motor Deficits in a Mouse Model of Parkinson’s Disease via Gut Microbiota-GLP-1 Pathway. Brain, Be-havior, and Immunity, 91, 703-715. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Sharma, G., Garg, N., Hasan, S., et al. (2022) Prevotella: An Insight into Its Characteristics and Associated Virulence Factors. Microbial Pathogenesis, 169, Article ID: 105673. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
Tran, T.T.T., Corsini, S., Kellingray, L., et al. (2019) APOE Genotype Influences the Gut Microbiome Structure and Function in Humans and Mice: Relevance for Alzheimer’s Dis-ease Pathophysiology. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Bi-ology, 33, 8221-8231. [Google Scholar] [CrossRef]
|
|
[53]
|
Li, B., He, Y., Ma, J., et al. (2019) Mild Cognitive Impairment Has Similar Alterations as Alzheimer’s Disease in Gut Microbiota. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 15, 1357-1366. [Google Scholar] [CrossRef] [PubMed]
|
|
[54]
|
Megur, A., Baltriukienė, D., Bukelskienė, V., et al. (2020) The Mi-crobiota-Gut-Brain Axis and Alzheimer’s Disease: Neuroinflammation Is to Blame? Nutrients, 13, Article No. 37. [Google Scholar] [CrossRef] [PubMed]
|
|
[55]
|
He, X., Yan, C., Zhao, S., et al. (2022) The Preventive Effects of Probi-otic Akkermansia Muciniphila on D-Galac- tose/AlCl3 Mediated Alzheimer’s Disease-Like Rats. Experimental Geron-tology, 170, Article ID: 111959. [Google Scholar] [CrossRef] [PubMed]
|
|
[56]
|
Grahnemo, L., Nethander, M., Coward, E., et al. (2022) Cross-Sectional Associations between the Gut Microbe Ruminococcus gnavus and Features of the Metabolic Syndrome. The Lancet Diabetes & Endocrinology, 10, 481-483. [Google Scholar] [CrossRef]
|
|
[57]
|
Nagpal, R., Neth, B.J., Wang, S., et al. (2019) Modified Mediterranean-Ketogenic Diet Modulates Gut Microbiome and Short-Chain Fatty Acids in Association with Alzheimer’s Disease Markers in Subjects with Mild Cognitive Impairment. EBioMedicine, 47, 529-542. [Google Scholar] [CrossRef] [PubMed]
|
|
[58]
|
Liu, M., Hu, R., Guo, Y., et al. (2020) Influence of Lactobacillus reuteri SL001 on Intestinal Microbiota in AD Model Mice and C57BL/6 Mice. Chinese Journal of Biotechnology, 36, 1887-1898.
|
|
[59]
|
Vascellari, S., Palmas, V., Melis, M., et al. (2020) Gut Microbiota and Metabolome Alterations Asso-ciated with Parkinson’s Disease. mSystems, 5, e00561-20. [Google Scholar] [CrossRef]
|
|
[60]
|
Underly, R., Song, M.S., Dunbar, G.L., et al. (2015) Expression of Alzheimer-Type Neurofibrillary Epitopes in Primary Rat Cortical Neurons Following Infection with Enterococcus faecalis. Frontiers in Aging Neuroscience, 7, Article No. 259. [Google Scholar] [CrossRef] [PubMed]
|
|
[61]
|
Gerhardt, S. and Mohajeri, M.H. (2018) Changes of Colonic Bacte-rial Composition in Parkinson’s Disease and Other Neurodegenerative Diseases. Nutrients, 10, Article No. 708. [Google Scholar] [CrossRef] [PubMed]
|